|
144
|
455
|
4p8cA |
Crystal structure of m. tuberculosis dpre1 in complex with the non-covalent inhibitor qn127 |
|
146
|
457
|
4p8lA |
Crystal structure of m. tuberculosis dpre1 in complex with the non-covalent inhibitor ty36c |
|
128
|
392
|
4pk5A |
Crystal structure of the indoleamine 2,3-dioxygenagse 1 (ido1) complexed with amg-1 |
|
101
|
268
|
4oxyA |
Substrate-binding loop movement with inhibitor pt10 in the tetrameric mycobacterium tuberculosis enoyl-acp reductase inha |
|
149
|
375
|
4ormA |
Crystal structure of plasmodium falciparum dihydroorotate dehydrogenase bound with inhibitor dsm338 (n-[3,5-difluoro-4-(trifluoromethyl)phenyl]-5-methyl-2-(trifluoromethyl)[1,2,4]triazolo[1,5-a]pyrimidin-7-amine) |
|
100
|
360
|
4qdfA |
Crystal structure of apo ksha5 and ksha1 in complex with 1,4-30q-coa from r. rhodochrous |
|
97
|
268
|
4oxnA |
Substrate-like binding mode of inhibitor pt155 to the mycobacterium tuberculosis enoyl-acp reductase inha |
|
95
|
267
|
4oxkA |
Multiple binding modes of inhibitor pt155 to the mycobacterium tuberculosis enoyl-acp reductase inha within a tetramer |
|
98
|
267
|
4oyrA |
Competition of the small inhibitor pt91 with large fatty acyl substrate of the mycobacterium tuberculosis enoyl-acp reductase inha by induced substrate-binding loop refolding |
|
99
|
265
|
4p38A |
Human 11beta-hydroxysteroid dehydrogenase type 1 in complex with azd8329 |
|
146
|
458
|
4p8yA |
Crystal structure of m. tuberculosis dpre1 in complex with the non-covalent inhibitor ty21c |
|
197
|
552
|
4otyA |
Crystal structure of lumiracoxib bound to the apo-mouse-cyclooxygenase-2 |
|
200
|
552
|
4otjA |
The complex of murine cyclooxygenase-2 with a conjugate of indomefathin and podophyllotoxin, n-{(succinylpodophyllotoxinyl)but-4-yl}-2-{1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indol-3-yl}acetamide |
|
134
|
454
|
4p8mA |
Crystal structure of m. tuberculosis dpre1 in complex with the non-covalent inhibitor qn114 |
|
150
|
456
|
4p8tA |
Crystal structure of m. tuberculosis dpre1 in complex with the non-covalent inhibitor qn129 |
|
108
|
315
|
4q7bA |
Human aldose reductase complexed with a ligand with an idd structure ([2-(benzylcarbamoyl)-5-fluorophenoxy]acetic acid) at 1.19 a |
|
101
|
337
|
4qfcA |
Co-crystal structure of compound 3 (4-hydroxy-6-[2-(7-hydroxy-2-oxo-4-phenyl-2h-chromen-6-yl)ethyl]pyridazin-3(2h)-one) and fad bound to human daao at 2.4a |
|
86
|
369
|
4qddA |
Crystal structure of 3-ketosteroid-9-alpha-hydroxylase 5 (ksha5) from r. rhodochrous in complex with 1,4-30q-coa |
|
123
|
392
|
4pk6A |
Crystal structure of the indoleamine 2,3-dioxygenagse 1 (ido1) complexed with imidazothiazole derivative |
|
170
|
453
|
4o4pA |
Structure of p450 bm3 a82f f87v in complex with s-omeprazol |
|
89
|
255
|
4nz9A |
Crystal structure of fabi from s. aureus in complex with a novel benzimidazole inhibitor |
|
134
|
471
|
4ny4A |
Crystal structure of cyp3a4 in complex with an inhibitor |
|
113
|
317
|
4nd1A |
Crystal structure of the lactate dehydrogenase from cryptosporidium parvum complexed with cofactor (b-nicotinamide adenine dinucleotide) and inhibitor (oxamic acid) |
|
104
|
345
|
4my8A |
Crystal structure of the inosine 5'-monophosphate dehydrogenase with an internal deletion of the cbs domain from bacillus anthracis str. ames complexed with inhibitor q21 |
|
141
|
482
|
4newA |
Crystal structure of trypanothione reductase from trypanosoma cruzi in complex with inhibitor ep127 (5-{5-[1-(pyrrolidin-1-yl)cyclohexyl]-1,3-thiazol-2-yl}-1h-indole) |
|
98
|
265
|
4nmhA |
11-beta-hsd1 in complex with a 3,3-di-methyl-azetidin-2-one |
|
106
|
314
|
4nkcA |
Human aldose reductase complexed with schl7764 at 1.12 a |
|
141
|
456
|
4ncrA |
Crystal structure of m. tuberculosis dpre1 in complex with pbtz169 |
|
38
|
159
|
4osgA |
Klebsiella pneumoniae complexed with nadph and 6-ethyl-5-[(3r)-3-[3-methoxyl-5-(pyridine-4-yl)phenyl]but-1-yn-1-yl]pyrimidine-2,4-diamine (ucp1006) |
|
197
|
553
|
4o1zA |
Crystal structure of ovine cyclooxygenase-1 complex with meloxicam |
|
100
|
267
|
4oimA |
Crystal structure of mycobacterium tuberculosis inha in complex with inhibitor pt119 in 2.4 m acetate |
|
131
|
361
|
4oriA |
Rat dihydroorotate dehydrogenase bound with dsm338 (n-[3,5-difluoro-4-(trifluoromethyl)phenyl]-5-methyl-2-(trifluoromethyl)[1,2,4]triazolo[1,5-a]pyrimidin-7-amine) |
|
127
|
519
|
4nhyA |
Crystal structure of human ogfod1, 2-oxoglutarate and iron-dependent oxygenase domain containing 1, in complex with pyridine-2,4-dicarboxylic acid (2,4-pdca) |
|
67
|
223
|
4nj4A |
Crystal structure of human alkbh5 |
|
139
|
362
|
4oqvA |
High resolution crystal structure of human dihydroorotate dehydrogenase bound with dsm338 (n-[3,5-difluoro-4-(trifluoromethyl)phenyl]-5-methyl-2-(trifluoromethyl)[1,2,4]triazolo[1,5-a]pyrimidin-7-amine) |
|
134
|
391
|
4oqrA |
Structure of a cyp105as1 mutant in complex with compactin |
|
45
|
165
|
4or7A |
Klebsiella pneumoniae dihydrofolate reductase complexed with nadph and 6-ethyl-5-{3-[3-(pyrimidin-5-yl)phenyl]prop-1-yn-1-yl}pyrimidine-2,4-diamine |
|
155
|
464
|
4nz2A |
Crystal structure of cyp2c9 in complex with an inhibitor |
|
191
|
613
|
4nhkA |
Crystal structure of tpa1p from saccharomyces cerevisiae, termination and polyadenylation protein 1, in complex with pyridine-2,4-dicarboxylic acid (2,4-pdca) |
|
99
|
267
|
4ohuA |
Crystal structure of mycobacterium tuberculosis inha in complex with inhibitor pt92 |
|
191
|
613
|
4nhmA |
Crystal structure of tpa1p from saccharomyces cerevisiae, termination and polyadenylation protein 1, in complex with n-[(1-chloro-4-hydroxyisoquinolin-3-yl)carbonyl]glycine (iox3/un9) |
|
187
|
613
|
4nhlA |
Crystal structure of tpa1p from saccharomyces cerevisiae, termination and polyadenylation protein 1, in complex with n-oxalylglycine (nog) |
|
140
|
485
|
4nevA |
Crystal structure of trypanothione reductase from trypanosoma brucei in complex with inhibitor ep127 (5-{5-[1-(pyrrolidin-1-yl)cyclohexyl]-1,3-thiazol-2-yl}-1h-indole) |
|
129
|
519
|
4nhxA |
Crystal structure of human ogfod1, 2-oxoglutarate and iron-dependent oxygenase domain containing 1, in complex with n-oxalylglycine (nog) |
|
114
|
379
|
4mz8A |
Crystal structure of the inosine 5'-monophosphate dehydrogenase, with an internal deletion of cbs domain from campylobacter jejuni complexed with inhibitor compound c91 |
|
107
|
360
|
4myaA |
Crystal structure of the inosine 5'-monophosphate dehydrogenase with an internal deletion of the cbs domain from bacillus anthracis str. ames complexed with inhibitor a110 |
|
102
|
363
|
4myxA |
Crystal structure of the inosine 5'-monophosphate dehydrogenase, with a internal deletion of cbs domain from bacillus anthracis str. ame complexed with p32 |
|
108
|
362
|
4my9A |
Crystal structure of the inosine 5'-monophosphate dehydrogenase with an internal deletion of the cbs domain from bacillus anthracis str. ames complexed with inhibitor c91 |
|
102
|
362
|
4my1A |
Crystal structure of the inosine 5'-monophosphate dehydrogenase, with a internal deletion of cbs domain from bacillus anthracis str. ames complexed with p68 |
|
111
|
380
|
4mz1A |
Crystal structure of the inosine 5'-monophosphate dehydrogenase, with a internal deletion of cbs domain from campylobacter jejuni complexed with inhibitor compound p12 |
